Takeda Pharmaceutical Company Limited 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-26 07:08 am Sale | 2023-04-17 | 13D | Calithera Biosciences, Inc. CALA | Takeda Pharmaceutical Company Limited | 0 0.000% | -857,844 (Position Closed) | Filing |
| 2022-07-06 06:12 am Purchase | 2022-07-01 | 13D | Calithera Biosciences, Inc. CALA | Takeda Pharmaceutical Company Limited | 857,844 15.000% | 116,970 (+15.79%) | Filing |
| 2022-04-21 06:06 am Purchase | 2021-10-18 | 13D | Calithera Biosciences, Inc. CALA | Takeda Pharmaceutical Company Limited | 740,874 13.200% | 740,874 (New Position) | Filing |